EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Making target sites in large structured RNAs accessible to RNA-cleaving DNAzymes through hybridization with synthetic DNA oligonucleotides

Connor Nurmi, Jimmy Gu, Amal Mathai, John D Brennan iD, Yingfu Li iD

Nucleic Acids Research · 2024

DOI: 10.1093/nar/gkae778 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Connor Nurmi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biomedical Sciences, McMaster University, Ontario L8S 4L8, Canada. Hauptthemen laut MEDLINE: DNA, Catalytic, SARS-CoV-2, RNA, Viral. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Sciences and Engineering Research Council of Canada, CIHR, Canadian Institutes of Health Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The 10–23 DNAzyme is one of the most active DNA-based enzymes, and in theory, can be designed to target any purine-pyrimidine junction within an RNA sequence for cleavage. However, purine-pyrimidine junctions within a large, structured RNA (lsRNA) molecule of biological origin are not always accessible to 10–23, negating its general utility as an RNA-cutting molecular scissor. Herein, we report a generalizable strategy that allows 10–23 to access any purine-pyrimidine junction within an lsRNA. Using three large SARS-CoV-2 mRNA sequences of 566, 584 and 831 nucleotides in length as model systems, we show that the use of antisense DNA oligonucleotides (ASOs) that target the upstream and downstream regions flanking the cleavage site can restore the activity (kobs) of previously poorly active 10–23 DNAzyme systems by up to 2000-fold. We corroborated these findings mechanistically using in-line probing to demonstrate that ASOs reduced 10–23 DNAzyme target site structure within the lsRNA substrates. This approach represents a simple, efficient, cost-effective, and generalizable way to improve the accessibility of 10–23 to a chosen target site within an lsRNA molecule, especially where direct access to the genomic RNA target is necessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA, CatalyticSARS-CoV-2RNA, ViralNucleic Acid HybridizationOligonucleotides, AntisenseNucleic Acid ConformationRNA CleavageRNA, MessengerCOVID-19RNADNA, Single-Stranded

Substanzen

DNA, CatalyticRNA, ViralOligonucleotides, AntisenseRNA-cleaving DNA 10-23RNA, MessengerRNADNA, Single-Stranded

Autor:innen und Institutionen

  • Department of Biochemistry and Biomedical Sciences, McMaster University, Ontario L8S 4L8, Canada.
  • Biointerfaces Institute, McMaster University, Ontario L8S 4L8, Canada.

ORCID-Profile: John D Brennan, Yingfu Li

Förderung

  • Natural Sciences and Engineering Research Council of Canada
  • CIHR
  • Canadian Institutes of Health Research

Zitieren

APA

Nurmi, C., Gu, J., Mathai, A., Brennan, J. D., & Li, Y. (2024). Making target sites in large structured RNAs accessible to RNA-cleaving DNAzymes through hybridization with synthetic DNA oligonucleotides. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae778

Vancouver

Nurmi C, Gu J, Mathai A, Brennan JD, Li Y. Making target sites in large structured RNAs accessible to RNA-cleaving DNAzymes through hybridization with synthetic DNA oligonucleotides. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae778

BibTeX
@article{Nurmi2024,
  author = {Nurmi, Connor and Gu, Jimmy and Mathai, Amal and Brennan, John D and Li, Yingfu},
  title = {Making target sites in large structured RNAs accessible to RNA-cleaving DNAzymes through hybridization with synthetic DNA oligonucleotides},
  journal = {Nucleic Acids Research},
  year = {2024},
  doi = {10.1093/nar/gkae778}
}
Kostenlos starten →